BioLineRx (BLRX) EBITDA (2013 - 2025)
BioLineRx (BLRX) recorded quarterly EBITDA of -$2.2 million in Q4 2025, down 128.86% quarter-over-quarter from -$977000.0 in Q3 2025, and up 29.84% on a YoY basis from -$1.7 million in Q4 2024.
BioLineRx (BLRX) EBITDA (2013 - 2025) Analysis & Trends
BioLineRx's EBITDA history runs 13 years deep, the most recent figure standing at -$2.2 million for Q4 2025.
- In Q4 2025, EBITDA rose 29.84% year-over-year to -$2.2 million; the TTM figure through Dec 2025 stood at -$2.0 million (up 78.03% YoY), while the FY2025 annual figure was -$2.0 million, up 78.03% from the prior year.
- EBITDA was -$2.2 million for Q4 2025 at BioLineRx, down from -$977000.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of $42.9 million in Q2 2023 to a low of -$39.8 million in Q3 2021.
- Historically, EBITDA has averaged -$3.3 million across 5 years, with a median of -$4.6 million in 2021.
- Biggest YoY gain for EBITDA was 836.64% in 2025; the steepest drop was 533.92% in 2025.
- A 5-year view of EBITDA shows it stood at -$4.3 million in 2021, then sank by 95.12% to -$8.4 million in 2022, then tumbled by 121.08% to -$18.6 million in 2023, then jumped by 82.83% to -$3.2 million in 2024, then climbed by 29.84% to -$2.2 million in 2025.
- The last three EBITDA figures came in at -$2.2 million (Q4 2025), -$977000.0 (Q3 2025), and -$3.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | BioLineRx | 227.63 Mn | 211.90 Mn | 154,000.00 | -2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.24 Mn |
| Sep 30, 2025 | -977,000.00 |
| Jun 30, 2025 | -3.94 Mn |
| Mar 31, 2025 | 5.13 Mn |
| Dec 31, 2024 | -3.19 Mn |
| Sep 30, 2024 | -6.25 Mn |
| Jun 30, 2024 | 908,000.00 |
| Mar 31, 2024 | -696,000.00 |
| Dec 31, 2023 | -18.57 Mn |
| Sep 30, 2023 | -12.36 Mn |
| Jun 30, 2023 | 42.87 Mn |
| Mar 31, 2023 | -12.16 Mn |
| Dec 31, 2022 | -8.40 Mn |
| Sep 30, 2022 | -7.08 Mn |
| Jun 30, 2022 | -7.60 Mn |
| Mar 31, 2022 | -4.93 Mn |
| Dec 31, 2021 | -4.30 Mn |
| Sep 30, 2021 | -39.78 Mn |
| Jun 30, 2021 | 27.23 Mn |
| Mar 31, 2021 | -10.19 Mn |